Variables | Whole (n = 89) | Treatment with PPIs | ||
---|---|---|---|---|
Omeprazole (n = 35) | Lansoprazole (n = 54) | |||
Age, years | 51.9 ± 10.3 | 52.4 ± 8.8 | 51.6 ± 11.2 | |
Gender (male/female), n | 46/43 | 19/16 | 27/27 | |
Body weight, kg | 60.0 ± 10.0 | 59.8 ± 10.2 | 60.1 ± 9.9 | |
Graft-to-recipient weight ratio, % | 1.14 ± 0.30 | 1.15 ± 0.29 | 1.13 ± 0.30 | |
ABO blood group match (identical/compatible/incompatible), n | 60/12/17 | 24/4/7 | 36/8/10 | |
Primary disease, n | ||||
Cirrhosis | 70 | 30 | 40 | |
Primary biliary cirrhosis | 7 | 2 | 5 | |
Fulminant hepatic failure | 3 | 1 | 2 | |
Others | 9a | 2 | 7 | |
Donor age, years | 45.0 ± 13.2 | 46.0 ± 12.6 | 44.3 ± 13.6 | |
Donor gender (male/female), n | 50/39 | 18/17 | 32/22 |
↵ a The primary disease was biliary atresia, Budd-Chiari syndrome, nonalcoholic steatohepatitis, and primary sclerosing cholangitis.